An Analysis Of The Possible Protective Effect Of Antipsychotics For ...

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard Save Email Send to

• Clipboard
• My Bibliography
• Collections
• Citation manager

Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Subject: 1 selected item: 34215466 - PubMed To: From: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons

• Yes
• No

Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Full text links

Elsevier Science Free PMC article Full text links

Actions

CiteCollectionsAdd to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel Display options Display options Format AbstractPubMedPMID

Share

• Permalink Copy

Page navigation

• Title & authors
• Conflict of interest statement
• Similar articles
• Cited by
• References
• Publication types
• MeSH terms
• Substances
• LinkOut - more resources

Title & authors Conflict of interest statement Similar articles Cited by References Publication types MeSH terms Substances LinkOut - more resources Full text links CiteDisplay options Display options Format AbstractPubMedPMID No abstract available

PubMed Disclaimer

Conflict of interest statement

No author or immediate family member has financial relationships with commercial entities that might appear to represent a potential for conflict of interest.

Similar articles

• Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic. Nason I, Stein DT, Frank RG, Stein MB. Nason I, et al. Health Aff (Millwood). 2021 Jun;40(6):904-909. doi: 10.1377/hlthaff.2021.00028. Health Aff (Millwood). 2021. PMID: 34097524
• Antipsychotics modified COVID-19 prevalence in hospitalized patients diagnosed with mental illnesses. Tendilla-Beltrán H, Carbajal-Rimoldi LA, Flores F, Gómez-Mendoza LE, Loaiza G, Flores G. Tendilla-Beltrán H, et al. Gen Hosp Psychiatry. 2023 Sep-Oct;84:250-252. doi: 10.1016/j.genhosppsych.2023.04.009. Epub 2023 Apr 20. Gen Hosp Psychiatry. 2023. PMID: 37098446 Free PMC article. No abstract available.
• Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population. Canal-Rivero M, Catalán-Barragán R, Rubio-García A, Garrido-Torres N, Crespo-Facorro B, Ruiz-Veguilla M; IBIS Translational Psychiatry Group. Canal-Rivero M, et al. Schizophr Res. 2021 Mar;229:53-54. doi: 10.1016/j.schres.2021.02.002. Epub 2021 Feb 19. Schizophr Res. 2021. PMID: 33631466 Free PMC article. No abstract available.
• [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic]. Javelot H, Llorca PM, Drapier D, Fakra E, Hingray C, Meyer G, Dizet S, Egron A, Straczek C, Roser M, Masson M, Gaillard R, Fossati P, Haffen E. Javelot H, et al. Encephale. 2020 Jun;46(3S):S14-S34. doi: 10.1016/j.encep.2020.04.006. Epub 2020 May 4. Encephale. 2020. PMID: 32376004 Free PMC article. Review. French.
• Using antipsychotic agents in older patients. Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. Alexopoulos GS, et al. J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.

See all similar articles

Cited by

• Antipsychotics, COVID-19, and Secondary Healthcare Databases: Revisiting the Pandemic. Boland X, Dratcu L. Boland X, et al. Int J Neuropsychopharmacol. 2024 Jul 1;27(7):pyae026. doi: 10.1093/ijnp/pyae026. Int J Neuropsychopharmacol. 2024. PMID: 38878266 Free PMC article. No abstract available.
• Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study. Pintos-Rodríguez S, Visos-Varela I, Rodríguez-Fernández A, Zapata-Cachafeiro M, Piñeiro-Lamas M, Herdeiro MT, García-Álvarez RM, Figueiras A, Salgado-Barreira Á. Pintos-Rodríguez S, et al. Int J Neuropsychopharmacol. 2024 Apr 1;27(4):pyae020. doi: 10.1093/ijnp/pyae020. Int J Neuropsychopharmacol. 2024. PMID: 38600711 Free PMC article.
• Exploring the Impact of COVID-19 Vaccination on Patients Taking Clozapine. Demler TL, O'Donnell C. Demler TL, et al. Innov Clin Neurosci. 2023 Jan-Mar;20(1-3):32-38. Innov Clin Neurosci. 2023. PMID: 37122573 Free PMC article.
• Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study. Canal-Rivero M, Vázquez-Hernández J, León-Gómez M, Maraver-Ayala S, Fernández-Portes L, Sánhez-Benítez S, Garrido-Torres N, Ruiz-Veguilla M, Crespo-Facorro B. Canal-Rivero M, et al. Schizophr Res. 2023 Apr;254:1-7. doi: 10.1016/j.schres.2023.01.020. Epub 2023 Jan 20. Schizophr Res. 2023. PMID: 36736100 Free PMC article.
• Clozapine Therapy and COVID-19: A Systematic Review of the Prevalence Rates, Health Outcomes, Hematological Markers, and Patient Perspectives. Giles G, Varghese S, Shymko G, Nguyen T, Waters F. Giles G, et al. Schizophr Bull. 2023 Jan 3;49(1):53-67. doi: 10.1093/schbul/sbac148. Schizophr Bull. 2023. PMID: 36242537 Free PMC article.

See all "Cited by" articles

References

1. 1. Chen T., Wu D., Chen H., Yan W., Yang D., Chen G., Ma K., Xu D., Yu H., Wang H. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368 - PMC - PubMed
2. 1. de Pellón Santamaría Á.R. Psychosis treatment during COVID-19 pandemic and the potential role of phenothiazines: a call for research studies. J. Clin. Psychopharmacol. 2020;40(6):641–642. - PubMed
3. 1. Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., O’Meara M.J., Rezelj V.V., Guo J.Z., Swaney D.L. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020:1–13. - PMC - PubMed
4. 1. Grasselli G., Greco M., Zanella A., Albano G., Antonelli M., Bellani G., Bonanomi E., Cabrini L., Carlesso E., Castelli G. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern. Med. 2020;180(10):1345–1355. - PMC - PubMed
5. 1. Javelot H., Petrignet J., Addiego F., Briet J., Solis M., El-Hage W., Hingray C., Weiner L. Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances. Med. Hypotheses. 2020;144 - PMC - PubMed

Show all 8 references

Publication types

• Letter Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Antipsychotic Agents* / therapeutic use Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• COVID-19* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Mental Disorders* / drug therapy Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• SARS-CoV-2 Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Antipsychotic Agents Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal

Full text links [x] Elsevier Science Free PMC article [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To

• Clipboard
• Email
• Save
• My Bibliography
• Collections
• Citation Manager

[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.